Fentanyl Positivity Rates Seven Times Higher in Random vs Pre-Employment Drug Tests
The sharp increase in fentanyl in random drug checks suggests more workers are using the opioid after they have passed pre-employment screens.
The sharp increase in fentanyl in random drug checks suggests more workers are using the opioid after they have passed pre-employment screens.
Researchers developed a urine-based diagnostic kit for bladder cancer, offering a solution for early detection and monitoring at home.
Biotia’s BIOTIA-ID Urine NGS Assay uses artificial intelligence (AI) and genomics to deliver rapid, highly accurate UTI diagnoses.
The CLP March/April 2024 Tech Guide in Clinical Lab Products (CLP) showcases a diverse array of products from seven laboratory providers.
Read MoreGeorge Mason University researchers have been awarded over $1 million to develop a urine-based Lyme disease test.
Read MoreA new study collected data on drug use by swabbing smartphone surfaces and analyzing residues. There are limitations to the method, however.
Read MoreResearchers developed a urine-based test utilizing whole genome sequencing to detect DNA fragments released by head and neck tumors.
Read MoreQuidelOrtho added the immunoassay for the qualitative detection of fentanyl to its Vitros systems to address the need for opioid testing.
Read MoreNanostics announced an agreement with Alberta Health Services to help drive diagnostic and prognostic innovations in urological care.
Read MoreThe new drug screening technique can rapidly detect the presence of 40 forensically relevant drugs from urine samples.
Read MoreTianeptine is often described as “gas-station dope” and products containing tianeptine commonly use the street names of “ZaZa” or “Tianna.”
Read MorePathogenDx’s UTI test is built on its D3 Array Platform. The multiplex test has a quick turnaround time with less waste.
Read MoreThe new panel from Quest tests for 88 compounds, and covers a broad array of drug classes, and other illicit additives.
Read MoreThis product design aims to transform workflows, expediting results for labs tasked to provide care for victims of drug-facilitated crimes.
Read MoreResearchers reported the enhanced performance of urinary biomarkers compared to plasma biomarkers for disease detection.
Read MoreShenzhen Superbio Technology received FDA clearance for a point-of-care instrument intended for the detection of fentanyl in human urine.
Read MoreKeystone Lab has officially added xylazine to its in-house urine clinical toxicology menu.
Read MoreHarmGuard FX is a single, low-cost test strip that provides an affordable, reliable way for people to test for fentanyl and xylazine.
Read More